IL9 and neoplasm: More IL-9 receptor-expressing tumor-infiltrating leukocytes were observed after the vvDD-IL-9 treatment compared to the vvDD treatment (Figure 4D), indicating that the IL-9/IL-9 receptor signal pathways are involved in the antitumor effects elicited by vvDD-IL-9 treatment.